Evidence map›Paper›PMID 36102827›Full record

ArticleEuropean journal of endocrinology2022

Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool.

Marianna Minnetti, Valeria Hasenmajer, Emilia Sbardella, Francesco Angelini, Chiara Simeoli, Nicola Di Paola, Alessia Cozzolino, Claudia Pivonello, Dario De Alcubierre, Sabrina Chiloiro and 5 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Unusual infections and thrombotic events in Cushing's syndrome.Journal of endocrinological investigation · 2025
    Review
  12. The Role of Stress Hyperglycemia on Delirium Onset.Journal of clinical medicine · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Marianna MinnettiDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.ORCID 0000-0002-9091-2809
Valeria HasenmajerDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.ORCID 0000-0003-4301-6662
Emilia SbardellaDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.ORCID 0000-0002-2220-9783
Francesco AngeliniDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.
Chiara SimeoliDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.ORCID 0000-0003-4275-337X
Nicola Di PaolaDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.
Alessia CozzolinoDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.ORCID 0000-0001-8614-5873
Claudia PivonelloDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.ORCID 0000-0003-4276-8600
Dario De AlcubierreDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.ORCID 0000-0001-5242-1761
Sabrina ChiloiroPituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.ORCID 0000-0001-9241-2392
Roberto BaldelliEndocrinology Unit, Department of Oncology and Medical Specialties, A.O. San Camillo-Forlanini, Rome, Italy.
Laura De MarinisPituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Rosario PivonelloDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.ORCID 0000-0002-9632-1348
Riccardo PofiDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.ORCID 0000-0001-7808-5735
Andrea M IsidoriDepartment of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I Hospital, Rome, Italy.ORCID 0000-0002-9037-5417
Policlinico Umberto I · ITUniversity of Naples Federico II · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Registry data show that Cushing's syndrome (CS) and adrenal insufficiency (AI) increase mortality rates associated with infectious diseases. Little information is available on susceptibility to milder forms of infections, especially those not requiring hospitalization. This study aimed to investigate infectious diseases in patients with glucocorticoid disorders through the development of a specific tool. Methods: We developed and administered the InfeCtions in pAtients with endocRinOpathies (ICARO) questionnaire, addressing infectious events over a 12-month observation period, to 1017 outpatients referred to 4 University Hospitals. The ICARO questionnaire showed good test-retest reliability. The odds of infection (OR (95% CI)) were estimated after adjustment for confounders and collated into the ICARO score, reflecting the frequency and duration of infections. Results: In total, 780 patients met the inclusion criteria: 43 with CS, 32 with adrenal incidentaloma and mild autonomous cortisol secretion (MACS), and 135 with AI, plus 570 controls. Compared to controls, CS was associated with higher odds of urinary tract infections (UTIs) (5.1 (2.3-9.9)), mycoses (4.4 (2.1-8.8)), and flu (2.9 (1.4-5.8)). Patients with adrenal incidentaloma and MACS also showed an increased risk of UTIs (3.7 (1.7-8.0)) and flu (3.2 (1.5-6.9)). Post-dexamethasone cortisol levels correlated with the ICARO score in patients with CS. AI was associated with higher odds of UTIs (2.5 (1.6-3.9)), mycoses (2.3 (1.4-3.8)), and gastrointestinal infections (2.2 (1.5-3.3)), independently of any glucocorticoid replacement dose. Conclusions: The ICARO tool revealed a high prevalence of self-reported infections in patients with glucocorticoid disorders. ICARO is the first of its kind questionnaire, which could be a valuable tool for monitoring infections in various clinical settings.

Indexed as

Adrenal Gland NeoplasmsAdrenal InsufficiencyCushing SyndromeDexamethasoneGlucocorticoidsHumansHydrocortisoneReproducibility of ResultsDexamethasoneGlucocorticoidsHydrocortisone

Identifiers

PMID36102827
PMCPMC9641788
OpenAlexW4295693300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.